Critical analysis on the use of cholecalciferol as a COVID-19 intervention: a narrative review
Authors:
- Stephanye Carolyne Christino ChagasSCStephanye Carolyne Christino Chagas
- Francisca Sueli Monte MoreiraFMFrancisca Sueli Monte Moreira
- Irla Carla França BarbosaIBIrla Carla França Barbosa
- Osvaldo de Sousa Leal JúniorOJOsvaldo de Sousa Leal Júnior
- Leila Bastos LealLeila Bastos Leal
- Davi Pereira de SantanaDSDavi Pereira de Santana
Open Access
- 24 December 2020
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 139 (1) , 81-87
Abstract
BACKGROUND: The World Health Organization has declared that a pandemic situation exists in relation to the disease caused by the new coronavirus, COVID-19. So far, the absence of a vaccine against the new coronavirus has led people worldwide to seek various therapeutic alternatives, including use of cholecalciferol. DESIGN AND SETTING: Narrative review developed by a research group at a public university in Recife (PE), Brazil. METHODS: We searched the literature on the use of cholecalciferol for prevention or treatment of COVID-19, using the MEDLINE and LILACS databases, with the keywords “vitamin D”, “cholecalciferol”, “SARS-CoV-2”, “COVID-19” and “coronavirus”, from January 1, 2020, to June 10, 2020. Narrative reviews, cohort studies and ecological studies were selected. RESULTS: We retrieved 32 references, of which 8 were considered eligible for intensive review and critical analysis. These comprised five narrative reviews, two observational studies and one protocol proposal. Most of the studies selected reported positive effects from use of vitamin D for prevention or treatment of COVID-19. However, there was little quantitative data to assess the real impact of using this vitamin as an intervention against this disease. CONCLUSIONS: Current studies on vitamin D used for purposes other than bone health promotion cannot be taken as support to justify its use in a disease as recent as COVID-19. Studies of greater robustness, with higher levels of clinical evidence, need to be conducted. Rational use of this vitamin needs to be ensured, thereby minimizing the impacts on the patient and the public healthcare system.Keywords
This publication has 31 references indexed in Scilit:
- Systemic review on drug related hospital admissions – A pubmed based searchSaudi Pharmaceutical Journal, 2015
- Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: a randomized controlled trialFood & Function, 2014
- 25-Hydroxyvitamin D Insufficiency and Deficiency is Associated With HIV Disease Progression and Virological Failure Post-Antiretroviral Therapy Initiation in Diverse Multinational SettingsThe Journal of Infectious Diseases, 2014
- Vitamina D: ações extraósseas e uso racionalRevista da Associação Médica Brasileira, 2013
- Vitamin D and the anti-viral stateJournal of Clinical Virology, 2011
- Vitamin D InsufficiencyNew England Journal of Medicine, 2011
- Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM studyValue in Health, 2011
- Iniciativa STROBE: subsídios para a comunicação de estudos observacionaisRevista de Saúde Pública, 2010
- Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildrenThe American Journal of Clinical Nutrition, 2010
- Risk assessment for vitamin DThe American Journal of Clinical Nutrition, 2007